Timeless Wealth
Contributor since: 2010
Company: Timeless Wealth
Latest Articles
The $15 Billion Patent-Play In Trovagene
Ex-Rabbi Turned Investment Manager Spots Information Arbitrage In These 2 Companies
Trovagene Poised To Lead The Next Generation Of Molecular Diagnostics Technology
What This News Means For Healthcare Stocks
Repros Therapeutics: More Holes Than A Block Of Swiss Cheese
Institutional Investors Bet On Prolor, Synergy, Arena Pharmaceuticals
4 Healthcare Stocks Breaking Out Mid-Week
NovaBay: Tomorrow's Staple In Antimicrobial Therapy?
Reading Into Prolor's Technology Offering: Major Partnership On The Horizon
Oculus: Financial Distress, Concentration Risk, And Other Red Flags
Ampio Shares To Rise In Advance Of Optina Data
How Qnexa's Positive Panel Review Generated Alpha For Short Sellers
Verastem Valued At Premium, InVivo Worth Even More On Innovative Therapy
Ampio Pharmaceuticals: Anti-Inflammatory Medicine Awaits FDA Guidance On Pivotal Juncture
Big Pharma, Take Note: Prolor Biotech's CTP Technology Yields Bio-Better Proteins
Interview: Ampio Pharmaceuticals' CEO Tackles 'Unanswered Questions'
Antares' Sell-Off Overdone
Ampio Pharmaceuticals: Anywhere But Straight Out Of Isolagen's Playbook
NovaBay Pharmaceuticals: Galderma Partnership Suggests Untapped Value
The Beneficiaries of Geron's Exit From Stem Cell Therapy
InVivo's Innovative Instigation In Spinal Cord Injury
High Power International: 5 Reasons To Call It A Growth Story
Ampio's Zertane: A Multi-Purpose Drug Potentially Worth Multi-Billions
Emerging Technologies In Brain Cancer Therapy
5 Healthcare Stocks To Consider
Ampio Provides a Healthcare Sector Opportunity Amid a Tantrum of Selling
Adventrx Pharmaceuticals: Undervalued Based on Product Approval Potential
Uplisting May Be Next For ImmunoCellular Therapeutics
ChromaDex: How an Insider Piqued My Interest
CytRx: Small Oncology Firm Offers Unique Exposure to Big Pharma Culture
ImmunoCellular Therapeutics Ramps Up Value Proposition With Recent Deals
Investing in Cancer Therapy? Consider Companies Engaged in Immunotherapy